Ginkgo Bioworks

Ginkgo Bioworks   (Biotechnology, Big pharma)
Formation	2009
Headquarters	Boston, Massachusetts, USA
Interests	synthetic biology
Membership	• Tom Knight • Jason Kelly • Reshma Shetty • Barry Canton • Austin Che • Christina Agapakis • Ryan Morhard
"Designs, engineers, develops, tests and licenses organisms”

Ginkgo Bioworks was founded in 2009 by a group of MIT scientists focused on “engineering biology” for a variety of purposes.

Officially, Ginkgo Bioworks “designs, engineers, develops, tests and licenses organisms”. The company refers to their work as “biology by design”, stating that they “program cells to make everything from food to materials to therapeutics.”

Ginkgo Bioworks work in a sector of biotechnology called synthetic biology (synbio), which is the intersection of biology and technology. The ultimate goal of this field is to replace factories with biological foundries that can produce everything we need directly (with a little genetic tweaking) from nature.

The company collaborates with DARPA, and in November 2020 the U.S. government granted Ginkgo a $1.1 billion loan for “COVID-19 testing and the production of raw materials for therapies that may help address future pandemics”.

Further Reading

• Who is Ginkgo Bioworks and How Do They Fit In the Bio-Security, Transhumanist Agenda? by Derek Broze

 

Known member

1 of the 7 of the members already have pages here:

Member	Description
Ryan Morhard	Works for Ginkgo Bioworks "building a platform to enable customers to program cells as easily as we can program computers"

Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.